BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10092634)

  • 21. Pseudomonas aeruginosa ExoS and ExoT.
    Barbieri JT; Sun J
    Rev Physiol Biochem Pharmacol; 2004; 152():79-92. PubMed ID: 15375697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pseudomonas aeruginosa exoenzyme S, a bifunctional type-III secreted cytotoxin.
    Barbieri JT
    Int J Med Microbiol; 2000 Oct; 290(4-5):381-7. PubMed ID: 11111915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic relationship between the 53- and 49-kilodalton forms of exoenzyme S from Pseudomonas aeruginosa.
    Yahr TL; Barbieri JT; Frank DW
    J Bacteriol; 1996 Mar; 178(5):1412-9. PubMed ID: 8631719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Residues of 14-3-3 zeta required for activation of exoenzyme S of Pseudomonas aeruginosa.
    Zhang L; Wang H; Masters SC; Wang B; Barbieri JT; Fu H
    Biochemistry; 1999 Sep; 38(37):12159-64. PubMed ID: 10508420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A nonphosphorylated 14-3-3 binding motif on exoenzyme S that is functional in vivo.
    Henriksson ML; Francis MS; Peden A; Aili M; Stefansson K; Palmer R; Aitken A; Hallberg B
    Eur J Biochem; 2002 Oct; 269(20):4921-9. PubMed ID: 12383250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of recombinant exoenzyme S of Pseudomonas aeruginosa.
    Kulich SM; Frank DW; Barbieri JT
    Infect Immun; 1995 Jan; 63(1):1-8. PubMed ID: 7806344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of glutamic acid 381 as a candidate active site residue of Pseudomonas aeruginosa exoenzyme S.
    Liu S; Kulich SM; Barbieri JT
    Biochemistry; 1996 Feb; 35(8):2754-8. PubMed ID: 8611582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The N-terminal domain of Pseudomonas aeruginosa exoenzyme S is a GTPase-activating protein for Rho GTPases.
    Goehring UM; Schmidt G; Pederson KJ; Aktories K; Barbieri JT
    J Biol Chem; 1999 Dec; 274(51):36369-72. PubMed ID: 10593930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exoenzyme S shows selective ADP-ribosylation and GTPase-activating protein (GAP) activities towards small GTPases in vivo.
    Henriksson ML; Sundin C; Jansson AL; Forsberg A; Palmer RH; Hallberg B
    Biochem J; 2002 Nov; 367(Pt 3):617-28. PubMed ID: 12132999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interruption of multiple cellular processes in HT-29 epithelial cells by Pseudomonas aeruginosa exoenzyme S.
    Olson JC; Fraylick JE; McGuffie EM; Dolan KM; Yahr TL; Frank DW; Vincent TS
    Infect Immun; 1999 Jun; 67(6):2847-54. PubMed ID: 10338490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Examination of the coordinate effects of Pseudomonas aeruginosa ExoS on Rac1.
    Rocha CL; Rucks EA; Vincent DM; Olson JC
    Infect Immun; 2005 Sep; 73(9):5458-67. PubMed ID: 16113262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pseudomonas aeruginosa exoenzyme S is a biglutamic acid ADP-ribosyltransferase.
    Radke J; Pederson KJ; Barbieri JT
    Infect Immun; 1999 Mar; 67(3):1508-10. PubMed ID: 10024602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exoenzyme S of Pseudomonas aeruginosa is not able to induce apoptosis when cells express activated proteins, such as Ras or protein kinase B/Akt.
    Jansson AL; Yasmin L; Warne P; Downward J; Palmer RH; Hallberg B
    Cell Microbiol; 2006 May; 8(5):815-22. PubMed ID: 16611230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eukaryotic cell determination of ExoS ADP-ribosyltransferase substrate specificity.
    Fraylick JE; Rucks EA; Greene DM; Vincent TS; Olson JC
    Biochem Biophys Res Commun; 2002 Feb; 291(1):91-100. PubMed ID: 11829467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ADP-ribosylation of Rab5 by ExoS of Pseudomonas aeruginosa affects endocytosis.
    Barbieri AM; Sha Q; Bette-Bobillo P; Stahl PD; Vidal M
    Infect Immun; 2001 Sep; 69(9):5329-34. PubMed ID: 11500402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 14-3-3 proteins are required for the inhibition of Ras by exoenzyme S.
    Henriksson ML; Trollér U; Hallberg B
    Biochem J; 2000 Aug; 349 Pt 3(Pt 3):697-701. PubMed ID: 10903129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exchange of glutamine-217 to glutamate of Clostridium limosum exoenzyme C3 turns the asparagine-specific ADP-ribosyltransferase into an arginine-modifying enzyme.
    Vogelsgesang M; Aktories K
    Biochemistry; 2006 Jan; 45(3):1017-25. PubMed ID: 16411778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell line differences in bacterially translocated ExoS ADP-ribosyltransferase substrate specificity.
    Rucks EA; Fraylick JE; Brandt LM; Vincent TS; Olson JC
    Microbiology (Reading); 2003 Feb; 149(Pt 2):319-331. PubMed ID: 12624194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The ARTT motif and a unified structural understanding of substrate recognition in ADP-ribosylating bacterial toxins and eukaryotic ADP-ribosyltransferases.
    Han S; Tainer JA
    Int J Med Microbiol; 2002 Feb; 291(6-7):523-9. PubMed ID: 11890553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The amino-terminal domain of Pseudomonas aeruginosa ExoS disrupts actin filaments via small-molecular-weight GTP-binding proteins.
    Pederson KJ; Vallis AJ; Aktories K; Frank DW; Barbieri JT
    Mol Microbiol; 1999 Apr; 32(2):393-401. PubMed ID: 10231494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.